These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8957487)

  • 1. Questionability of the benefits of routine laparotomy as the surgical approach for pheochromocytomas and abdominal paragangliomas.
    Pattou FN; Combemale FP; Poirette JF; Carnaille B; Wemeau JL; Huglo D; Ernst O; Proye CA
    Surgery; 1996 Dec; 120(6):1006-11; discussion 1012. PubMed ID: 8957487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and limits of preoperative imaging studies for the localisation of pheochromocytomas and paragangliomas: a review of 282 cases. French Association of Surgery (AFC), and The French Association of Endocrine Surgeons (AFCE).
    Jalil ND; Pattou FN; Combemale F; Chapuis Y; Henry JF; Peix JL; Proye CA
    Eur J Surg; 1998 Jan; 164(1):23-8. PubMed ID: 9537705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pheochromocytoma and paraganglioma: comparison of MR imaging with CT and I-131 MIBG scintigraphy.
    Quint LE; Glazer GM; Francis IR; Shapiro B; Chenevert TL
    Radiology; 1987 Oct; 165(1):89-93. PubMed ID: 3628794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of pheochromocytoma management in the laparoscopic era.
    Solorzano CC; Lew JI; Wilhelm SM; Sumner W; Huang W; Wu W; Montano R; Sleeman D; Prinz RA
    Ann Surg Oncol; 2007 Oct; 14(10):3004-10. PubMed ID: 17690941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR imaging and MIBG scintigraphy of pheochromocytomas and extraadrenal functioning paragangliomas.
    van Gils AP; Falke TH; van Erkel AR; Arndt JW; Sandler MP; van der Mey AG; Hoogma RP
    Radiographics; 1991 Jan; 11(1):37-57. PubMed ID: 1671719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iodine-131-metaiodobenzylguanidine scintigraphy in preoperative and postoperative evaluation of paragangliomas: comparison with CT and MRI.
    Maurea S; Cuocolo A; Reynolds JC; Tumeh SS; Begley MG; Linehan WM; Norton JA; Walther MM; Keiser HR; Neumann RD
    J Nucl Med; 1993 Feb; 34(2):173-9. PubMed ID: 8381474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of pheochromocytoma: MIBG [correction of MIGB], CT, and MRI correlation.
    Velchik MG; Alavi A; Kressel HY; Engelman K
    J Nucl Med; 1989 Mar; 30(3):328-36. PubMed ID: 2738662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of 131I-MIBG scintigraphy in the evaluation of suspected pheochromocytoma.
    Swensen SJ; Brown ML; Sheps SG; Sizemore GW; Gharib H; Grant CS; van Heerden JA
    Mayo Clin Proc; 1985 May; 60(5):299-304. PubMed ID: 3990377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic imaging in patients with paragangliomas. Computed tomography, magnetic resonance and MIBG scintigraphy comparison.
    Maurea S; Cuocolo A; Reynolds JC; Neumann RD; Salvatore M
    Q J Nucl Med; 1996 Dec; 40(4):365-71. PubMed ID: 9050342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of Somatostatin Receptor Scintigraphy (Tc-[HYNIC, Tyr3]-Octreotide) and 123I-Metaiodobenzylguanidine Scintigraphy in Patients with SDHx Gene-Related Pheochromocytomas and Paragangliomas Detected by Computed Tomography.
    Michałowska I; Ćwikła JB; Pęczkowska M; Furmanek MI; Buscombe JR; Michalski W; Prejbisz A; Szperl M; Malinoc A; Moczulski D; Szutkowski Z; Kawecki A; Antoniewicz J; Pęczkowski P; Lewczuk A; Otto M; Cichocki A; Bednarek-Tupikowska G; Kabat M; Janaszek-Sitkowska H; Przybyłowska K; Janas J; Neumann HP; Januszewicz A
    Neuroendocrinology; 2015; 101(4):321-30. PubMed ID: 25791839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization procedures in pheochromocytoma and neuroblastoma.
    Fischer M; Galanski M; Winterberg B; Vetter H
    Cardiology; 1985; 72 Suppl 1():143-6. PubMed ID: 3902227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limitations of 131I-MIBG scintigraphy in locating pheochromocytomas.
    Gough IR; Thompson NW; Shapiro B; Sisson JC
    Surgery; 1985 Jul; 98(1):115-20. PubMed ID: 2861667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of iodobenzylguanidine imaging with computed tomography in locating pheochromocytoma.
    Chatal JF; Charbonnel B
    J Clin Endocrinol Metab; 1985 Oct; 61(4):769-72. PubMed ID: 4031017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.
    Fiebrich HB; Brouwers AH; Kerstens MN; Pijl ME; Kema IP; de Jong JR; Jager PL; Elsinga PH; Dierckx RA; van der Wal JE; Sluiter WJ; de Vries EG; Links TP
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3922-30. PubMed ID: 19622618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early diagnosis of and surgical strategy for adrenal medullary disease in MEN II gene carriers.
    Jansson S; Tisell LE; Fjälling M; Lindberg S; Jacobsson L; Zachrisson BF
    Surgery; 1988 Jan; 103(1):11-8. PubMed ID: 2892276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
    van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
    J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of 123I-MIBG Scintigraphy in Paraganglioma.
    Milardovic R; Corssmit EP; Stokkel M
    Neuroendocrinology; 2010; 91(1):94-100. PubMed ID: 19786729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computed tomography and 131I-MIBG scintigraphy in the diagnosis of pheochromocytoma.
    Koizumi M; Endo K; Sakahara H; Nakashima T; Nakano Y; Nakao K; Torizuka K
    Acta Radiol Diagn (Stockh); 1986; 27(3):305-9. PubMed ID: 3751679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression.
    Fottner C; Helisch A; Anlauf M; Rossmann H; Musholt TJ; Kreft A; Schadmand-Fischer S; Bartenstein P; Lackner KJ; Klöppel G; Schreckenberger M; Weber MM
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2800-10. PubMed ID: 20371665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative localization of malignant pheochromocytoma by 123-I-metaiodobenzylguanidine single probe measurement.
    Lehnert H; Weber P; Nägele-Wöhrle B; von Bülow M; Eissner D; Schweden F; Junginger T; Schrezenmeir J; Krause U; Beyer J
    Klin Wochenschr; 1988 Jan; 66(2):61-4. PubMed ID: 3347006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.